Remove 2024 Remove EBITDA Remove Equity
article thumbnail

Growth Equity Interview Questions: Full List, Answers, and Differences vs. Venture Capital and Private Equity

Brian DeChesare

This site has already covered investment banking interview questions , private equity interview questions , and venture capital interview questions , so the next topic on the list seemed to be growth equity interview questions. Q: Why growth equity? Q: Walk me through your resume.

Equity 59
article thumbnail

Goodwin Procter Discusses Add-On Acquisitions in Private Equity

Reynolds Holding

As EBITDA and revenue multiples on larger platform acquisitions increased through 2021 and into the early part of 2022, many sponsors turned to consolidation and “buy and build” strategies, characterized by using smaller add-on acquisitions with lower price multiples to build value. This post comes to us from Goodwin Procter LLP.

Equity 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Private Equity Value Creation: Equally Viable Alternative to PE Deal Teams?

Brian DeChesare

Private equity value creation came on my radar a few years ago when I noticed something: Even though traditional PE deal roles were not doing well, “operational” or “value creation” teams still seemed to be recruiting. What Does the Private Equity Value Creation Team Do in Real Life? Why is PE Value Creation Suddenly “Hot”?

Equity 105
article thumbnail

Chancery Invalidates Elon Musk’s $55.8 Billion Equity Compensation Package

Harvard Corporate Governance

Posted by Sean Feller, Krista Hanvey, and Christina Andersen, Gibson, Dunn & Crutcher LLP, on Wednesday, February 21, 2024 Editor's Note: Sean Feller and Krista Hanvey are Partners, and Christina Andersen is Of Counsel at Gibson, Dunn & Crutcher LLP. The process arrived at an unfair price.” [3]

Equity 225
article thumbnail

Tornetta v. Musk: Post-Trial Opinion

Harvard Corporate Governance

Posted by Anna Restuccia (Harvard Law School), on Thursday, February 1, 2024 Editor's Note: This post provides the text of the post-trial opinion regarding the case between Richard J. against Elon Musk, decided by the Delaware Court of Chancery on January 30, 2024. Tornetta on behalf of Tesla, Inc. Varallo, Glenn R.

EBITDA 337
article thumbnail

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion

Benzinga

euros per share in cash, implying a fully diluted equity value of 2.0 The proposal represents a premium of 109% to Evotec’s undisturbed share price on October 15, 2024, the day before Triton Partners’ initial accumulation of Evotec shares. billion euros (around $2.11 Halozyme said. Full story available on Benzinga.com

EBITDA 52
article thumbnail

Retail Opportunity Investments Corp. Reports 2024 Third Quarter Results

Benzinga

22, 2024 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. NASDAQ: ROIC ) announced today financial and operating results for the three and nine months ended September 30, 2024. per diluted share) FFO per diluted share guidance for 2024 updated ($1.03 - $1.05 net principal debt-to-annualized EBITDA ratio for 3Q‘24 (vs.